Cargando…
Bacteriologically Determined De Novo Tuberculosis during Tumor Necrosis Factor-α Inhibitor Therapy
A 58-year-old man with Crohn's disease received adalimumab for 13 months after screening results for tuberculosis were found to be negative. He was diagnosed with de novo mediastinal lymph-node tuberculosis, which was proved to be bacteriologically identical to that of an individual with smear...
Autores principales: | Takahashi, Gen, Kobayashi, Hiroyuki, Saito, Yasuyuki, Ohsawa, Sho, Suzuki, Kuniaki, Ishihara, Shinichi, Hisada, Takeshi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Japanese Society of Internal Medicine
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6949445/ https://www.ncbi.nlm.nih.gov/pubmed/31434822 http://dx.doi.org/10.2169/internalmedicine.3054-19 |
Ejemplares similares
-
The Bacteriology of Tuberculosis
por: Henderson, J. R.
Publicado: (1958) -
Treatment with Tumor Necrosis Factor-α Inhibitors, History of Allergy, and Hypercalcemia Are Risk Factors of Immune Reconstitution Inflammatory Syndrome in HIV-Negative Pulmonary Tuberculosis Patients
por: Hachisu, Yoshimasa, et al.
Publicado: (2019) -
Paradoxical response with increased tumor necrosis factor-α levels to anti-tuberculosis treatment in a patient with disseminated tuberculosis
por: Watanabe, Sho, et al.
Publicado: (2017) -
Meningeal Tuberculosis: Bacteriology and Pathology
por: Macgregor, Agnes R., et al.
Publicado: (1935) -
Tuberculosis: Bacteriology, Pathology and Laboratory Diagnosis
Publicado: (1927)